Glycolipid Disialoganglioside-directed Antibody [EPC]

Glycolipid Disialoganglioside-directed Antibody [EPC] was reported 1085 times

Drugs of the Glycolipid Disialoganglioside-directed Antibody [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 MALIGNANT CRANIAL NERVE NEOPLASM 18 0.6923
1 HUMAN ANTI-MOUSE ANTIBODY INCREASED 1 0.5000
2 CENTRAL NERVOUS SYSTEM NEUROBLASTOMA 1 0.5000
3 NEUROBLASTOMA RECURRENT 89 0.4384
4 PUPILLOTONIA 2 0.4000
5 RETRO-ORBITAL NEOPLASM 18 0.3396
6 KIDNEY HYPERMOBILITY 1 0.2000
7 THALAMIC MICROHAEMORRHAGE 1 0.1667
8 NEUROBLASTOMA 58 0.1514
9 PROTEIN ALBUMIN RATIO DECREASED 3 0.1364
10 HUMAN ANTI-MOUSE ANTIBODY POSITIVE 2 0.1176
11 GUT DERIVED INFECTION 1 0.0909
12 MYXOMA 1 0.0714
13 CENTRAL NERVOUS SYSTEM MELANOMA 1 0.0625
14 PUNCTURE SITE ABSCESS 1 0.0556
15 PLATELET ANISOCYTOSIS 1 0.0435
16 CONGENITAL CENTRAL HYPOVENTILATION SYNDROME 1 0.0417
17 BRAIN STEM MICROHAEMORRHAGE 1 0.0357
18 RETROGRADE PORTAL VEIN FLOW 1 0.0323
19 PLEUROPARENCHYMAL FIBROELASTOSIS 3 0.0288
20 CITROBACTER SEPSIS 1 0.0250
21 NEURONE-SPECIFIC ENOLASE INCREASED 1 0.0233
22 EMOTIONAL DISORDER OF CHILDHOOD 1 0.0161
23 CAPILLARY LEAK SYNDROME 33 0.0159
24 CAPILLARY PERMEABILITY INCREASED 1 0.0154
25 ANAPLASTIC LYMPHOMA KINASE GENE MUTATION 1 0.0152
26 GANGLIONEUROMA 1 0.0152
27 ANTITHROMBIN III DECREASED 4 0.0147
28 PNEUMOCYSTIS TEST POSITIVE 1 0.0139
29 MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN 1 0.0139
30 NEUROGENIC BOWEL 3 0.0126
31 MYELITIS TRANSVERSE 17 0.0121
32 POST PROCEDURAL HYPOTENSION 1 0.0118
33 GROWTH DISORDER 3 0.0111
34 OSTEOSARCOMA METASTATIC 1 0.0105
35 ADENOVIRUS TEST POSITIVE 1 0.0105
36 FIBRIN DEGRADATION PRODUCTS INCREASED 3 0.0101
37 DELIRIUM FEBRILE 1 0.0096
38 BLOOD LACTATE DEHYDROGENASE DECREASED 3 0.0090
39 ABDOMINAL REBOUND TENDERNESS 1 0.0089
40 CLOSTRIDIAL SEPSIS 2 0.0083
41 BLOOD GROWTH HORMONE ABNORMAL 1 0.0082
42 PERIPORTAL OEDEMA 1 0.0080
43 NEUTRALISING ANTIBODIES 1 0.0079
44 SHORT STATURE 2 0.0076
45 DEVELOPMENTAL REGRESSION 1 0.0074
46 GENE MUTATION IDENTIFICATION TEST POSITIVE 3 0.0071
47 HYPOALBUMINAEMIA 55 0.0071
48 IIIRD NERVE DISORDER 1 0.0070
49 ENDOCARDITIS NONINFECTIVE 1 0.0067
50 SECONDARY AMYLOIDOSIS 1 0.0066
51 EPIPHYSES PREMATURE FUSION 2 0.0066
52 GASTRITIS BACTERIAL 3 0.0064
53 ACUTE MYELOID LEUKAEMIA REFRACTORY 1 0.0058
54 PNEUMOPERICARDIUM 1 0.0058
55 MULTISYSTEM INFLAMMATORY SYNDROME 1 0.0058
56 TRI-IODOTHYRONINE DECREASED 3 0.0057
57 TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 1 0.0055
58 METASTASES TO SPINE 18 0.0054
59 FUNGAEMIA 8 0.0051
60 BONE MARROW TOXICITY 6 0.0051
61 OPTIC ATROPHY 8 0.0049
62 RED BLOOD CELL TRANSFUSION 2 0.0049
63 THYROXINE DECREASED 3 0.0048
64 SERUM SICKNESS-LIKE REACTION 3 0.0048
65 REFRACTORY CANCER 1 0.0047
66 HEARING AID USER 2 0.0047
67 CARDIAC MYXOMA 1 0.0046
68 PNEUMATOSIS 2 0.0045
69 SUPERIOR MESENTERIC ARTERY SYNDROME 1 0.0045
70 PERIPHERAL VEIN THROMBOSIS 1 0.0042
71 CHYLOTHORAX 3 0.0042
72 POSTICTAL PARALYSIS 1 0.0041
73 ACCOMMODATION DISORDER 3 0.0041
74 RESPIRATORY TRACT OEDEMA 3 0.0040
75 PROLONGED EXPIRATION 1 0.0038
76 RESPIRATORY TRACT INFECTION FUNGAL 2 0.0038
77 URETERIC STENOSIS 3 0.0037
78 COOMBS TEST POSITIVE 1 0.0037
79 ANTIBODY TEST POSITIVE 6 0.0036
80 AGONAL RESPIRATION 1 0.0035
81 HUMAN HERPESVIRUS 6 ENCEPHALITIS 1 0.0035
82 URINARY TRACT INFECTION FUNGAL 2 0.0035
83 REFRACTION DISORDER 1 0.0034
84 FIBRIN D DIMER INCREASED 12 0.0034
85 PREMATURE MENOPAUSE 3 0.0032
86 GASTROENTERITIS ROTAVIRUS 1 0.0032
87 OTOTOXICITY 6 0.0032
88 PUPILLARY REFLEX IMPAIRED 6 0.0032
89 WHITE BLOOD CELLS URINE POSITIVE 6 0.0032
90 DEVICE PROGRAMMING ERROR 1 0.0032
91 PNEUMONIA LEGIONELLA 5 0.0031
92 RED BLOOD CELL SCHISTOCYTES PRESENT 1 0.0031
93 HYPERMAGNESAEMIA 2 0.0031
94 PERIPHERAL MOTOR NEUROPATHY 4 0.0029
95 FLUID IMBALANCE 2 0.0028
96 PORTAL VENOUS GAS 1 0.0028
97 NERVE COMPRESSION 25 0.0027
98 HUMAN RHINOVIRUS TEST POSITIVE 1 0.0027
99 HEART SOUNDS ABNORMAL 2 0.0027
100 ANISOCORIA 1 0.0026
101 BLOOD FIBRINOGEN DECREASED 3 0.0026
102 PUPILS UNEQUAL 3 0.0026
103 OSTEOSARCOMA 1 0.0026
104 CAPILLARY DISORDER 1 0.0026
105 INTRACRANIAL TUMOUR HAEMORRHAGE 1 0.0026
106 INCORRECT DRUG ADMINISTRATION RATE 11 0.0026
107 ADRENAL GLAND CANCER 1 0.0026
108 THROMBOTIC MICROANGIOPATHY 25 0.0026
109 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 2 0.0025
110 PRODUCT USED FOR UNKNOWN INDICATION 3 0.0024
111 TRANSPLANTATION COMPLICATION 1 0.0024
112 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 22 0.0023
113 PANCREATIC ATROPHY 1 0.0023
114 POSTRENAL FAILURE 1 0.0023
115 EYELID INFECTION 1 0.0023
116 FEEDING INTOLERANCE 1 0.0022
117 PROTEIN URINE 2 0.0022
118 LACRIMATION DECREASED 1 0.0021
119 PYELOCALIECTASIS 2 0.0021
120 HYPOREFLEXIA 4 0.0021
121 GASTROINTESTINAL TOXICITY 10 0.0021
122 BLOOD BICARBONATE INCREASED 1 0.0021
123 KNEE DEFORMITY 3 0.0020
124 MYDRIASIS 25 0.0019
125 LIVEDO RETICULARIS 4 0.0019
126 HYPOPERFUSION 2 0.0019
127 BRONCHOSPASM 27 0.0019
128 PHARYNGEAL MASS 1 0.0019
129 LARYNGOSPASM 5 0.0019
130 SCROTAL PAIN 1 0.0019
131 BRADYPNOEA 5 0.0019
132 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 4 0.0018
133 CARDIOTOXICITY 16 0.0018
134 HYPOXIA 63 0.0018
135 TREATMENT DELAYED 3 0.0017
136 EYELID OEDEMA 20 0.0017
137 TRANSAMINASES ABNORMAL 1 0.0017
138 URINE OUTPUT DECREASED 15 0.0017
139 FEBRILE INFECTION 2 0.0017
140 STRIDOR 5 0.0017
141 PULMONARY TOXICITY 12 0.0017
142 HYPERTENSIVE ENCEPHALOPATHY 1 0.0017
143 GRUNTING 1 0.0017
144 PUPILLARY DISORDER 1 0.0016
145 CATARACT SUBCAPSULAR 1 0.0016
146 GAMMA-GLUTAMYLTRANSFERASE INCREASED 36 0.0016
147 HYPOPHOSPHATAEMIA 12 0.0016
148 HYPERVOLAEMIA 8 0.0016
149 VENOOCCLUSIVE DISEASE 4 0.0016
150 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 8 0.0016
151 ABDOMINAL COMPARTMENT SYNDROME 1 0.0016
152 SEDATION COMPLICATION 4 0.0016
153 ANAL INFLAMMATION 1 0.0016
154 BODY HEIGHT BELOW NORMAL 1 0.0016
155 PLATELET TRANSFUSION 2 0.0016
156 LEUKOCYTOSIS 28 0.0015
157 TUMOUR PAIN 2 0.0015
158 FACE OEDEMA 25 0.0015
159 PARANEOPLASTIC SYNDROME 1 0.0015
160 NEURODEVELOPMENTAL DISORDER 1 0.0015
161 PAINFUL ERECTION 1 0.0015
162 ANTIBODY TEST ABNORMAL 1 0.0014
163 HEMIANOPIA HOMONYMOUS 1 0.0014
164 METASTASES TO LIVER 23 0.0013
165 MYELITIS 2 0.0013
166 METAPNEUMOVIRUS INFECTION 1 0.0013
167 BLOOD FIBRINOGEN INCREASED 1 0.0013
168 PULMONARY ALVEOLAR HAEMORRHAGE 7 0.0012
169 ASPARTATE AMINOTRANSFERASE INCREASED 65 0.0012
170 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
171 LEUKOCYTURIA 1 0.0012
172 DYSCHROMATOPSIA 1 0.0012
173 HAEMODYNAMIC INSTABILITY 9 0.0012
174 CANCER PAIN 3 0.0012
175 DEVICE RELATED INFECTION 18 0.0012
176 THERAPY PARTIAL RESPONDER 18 0.0012
177 TRANSFUSION REACTION 1 0.0011
178 CATHETER SITE PRURITUS 1 0.0011
179 UPPER AIRWAY OBSTRUCTION 1 0.0011
180 CONJUNCTIVAL HYPERAEMIA 4 0.0011
181 CANDIDA SEPSIS 1 0.0011
182 SUSPECTED OFF LABEL USE 5 0.0011
183 VENOUS OCCLUSION 2 0.0011
184 URINARY RETENTION 36 0.0011
185 TENDON INJURY 4 0.0011
186 DRUG TOLERANCE DECREASED 3 0.0011
187 MICROANGIOPATHY 1 0.0011
188 PROTHROMBIN LEVEL DECREASED 1 0.0011
189 HYPERBILIRUBINAEMIA 11 0.0011
190 HYPOPROTEINAEMIA 2 0.0011
191 CANCER SURGERY 1 0.0010
192 CLOSTRIDIUM DIFFICILE COLITIS 11 0.0010
193 ADENOVIRUS INFECTION 3 0.0010
194 ALANINE AMINOTRANSFERASE INCREASED 63 0.0010
195 MULTI-ORGAN DISORDER 2 0.0010
196 HYPERNATRAEMIA 5 0.0010
197 ANORECTAL DISORDER 2 0.0010
198 ANAPHYLACTOID REACTION 4 0.0010
199 CORONAVIRUS TEST POSITIVE 1 0.0010
200 EOSINOPHIL COUNT INCREASED 8 0.0010
201 METASTASES TO PLEURA 1 0.0010
202 APPLICATION SITE PAPULES 1 0.0009
203 EXOPHTHALMOS 2 0.0009
204 PNEUMONIA STREPTOCOCCAL 1 0.0009
205 DEAFNESS NEUROSENSORY 3 0.0009
206 OCULAR TOXICITY 1 0.0009
207 RESPIRATORY DISTRESS 24 0.0009
208 LOCALISED OEDEMA 4 0.0009
209 HAEMOLYTIC URAEMIC SYNDROME 2 0.0009
210 HYPORESPONSIVE TO STIMULI 1 0.0009
211 ACUTE LUNG INJURY 1 0.0008
212 STREPTOCOCCAL SEPSIS 1 0.0008
213 PNEUMONIA INFLUENZAL 1 0.0008
214 MYELODYSPLASTIC SYNDROME 12 0.0008
215 RENAL TUBULAR INJURY 1 0.0008
216 FEBRILE CONVULSION 1 0.0008
217 OXYGEN SATURATION DECREASED 46 0.0008
218 RESPIRATORY DEPRESSION 10 0.0008
219 LARYNGEAL OEDEMA 5 0.0008
220 VENOOCCLUSIVE LIVER DISEASE 4 0.0008
221 NEUTROPHIL COUNT DECREASED 33 0.0008
222 CARDIAC DYSFUNCTION 3 0.0008
223 NEOPLASM PROGRESSION 28 0.0008
224 TRISOMY 21 1 0.0008
225 GLUCOSE URINE PRESENT 1 0.0008
226 PALLOR 21 0.0008
227 SPINAL CORD COMPRESSION 3 0.0008
228 ENCEPHALITIS AUTOIMMUNE 1 0.0008
229 EXTRADURAL HAEMATOMA 1 0.0008
230 BRONCHIECTASIS 5 0.0007
231 EFFUSION 1 0.0007
232 DRUG SPECIFIC ANTIBODY 1 0.0007
233 RHONCHI 1 0.0007
234 VIRAEMIA 1 0.0007
235 PULSELESS ELECTRICAL ACTIVITY 3 0.0007
236 C-REACTIVE PROTEIN INCREASED 26 0.0007
237 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
238 PNEUMATOSIS INTESTINALIS 2 0.0007
239 METASTATIC NEOPLASM 3 0.0007
240 HORDEOLUM 3 0.0007
241 METASTASES TO LUNG 8 0.0007
242 BONE MARROW FAILURE 14 0.0007
243 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
244 IMMUNOSUPPRESSION 6 0.0007
245 GENITAL PAIN 1 0.0007
246 HISTIOCYTOSIS HAEMATOPHAGIC 2 0.0007
247 HYPOKALAEMIA 31 0.0007
248 HYDRONEPHROSIS 5 0.0007
249 PAPILLOEDEMA 3 0.0007
250 ADHESION 1 0.0007
251 SMALL CELL LUNG CANCER 1 0.0007
252 TACHYPNOEA 9 0.0007
253 VASCULAR DEVICE INFECTION 3 0.0007
254 NEURALGIA 16 0.0007
255 MENTAL STATUS CHANGES 18 0.0006
256 PULMONARY HAEMORRHAGE 5 0.0006
257 URINE KETONE BODY PRESENT 1 0.0006
258 CARDIAC TAMPONADE 3 0.0006
259 PNEUMONIA VIRAL 2 0.0006
260 PANCYTOPENIA 35 0.0006
261 METABOLIC ALKALOSIS 1 0.0006
262 HYPOTENSION 125 0.0006
263 SKULL FRACTURE 1 0.0006
264 INJECTION SITE INFLAMMATION 3 0.0006
265 DYSPHORIA 3 0.0006
266 OEDEMA 32 0.0006
267 BACTERAEMIA 7 0.0006
268 DEAFNESS BILATERAL 1 0.0006
269 PHOTOPHOBIA 11 0.0006
270 PUPIL FIXED 1 0.0006
271 SPLENIC INFARCTION 1 0.0006
272 SERUM FERRITIN INCREASED 3 0.0006
273 BLOOD LACTATE DEHYDROGENASE INCREASED 9 0.0006
274 PYREXIA 196 0.0006
275 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1 0.0006
276 GENERALISED OEDEMA 7 0.0006
277 BEHAVIOUR DISORDER 3 0.0006
278 PNEUMOMEDIASTINUM 1 0.0006
279 AMYLASE INCREASED 2 0.0005
280 BLADDER SPASM 1 0.0005
281 TUNNEL VISION 1 0.0005
282 PROTEIN TOTAL DECREASED 2 0.0005
283 HUMAN HERPESVIRUS 6 INFECTION 1 0.0005
284 PULMONARY HYPERTENSION 11 0.0005
285 GRANULOCYTOPENIA 3 0.0005
286 PROTEINURIA 10 0.0005
287 NEUROLOGICAL SYMPTOM 3 0.0005
288 HEPATIC MASS 1 0.0005
289 TRAUMATIC LUNG INJURY 1 0.0005
290 SINUS BRADYCARDIA 5 0.0005
291 METABOLIC DISORDER 3 0.0005
292 PNEUMONIA CYTOMEGALOVIRAL 1 0.0005
293 RHINOVIRUS INFECTION 2 0.0005
294 PERIPHERAL SENSORY NEUROPATHY 3 0.0005
295 GASTROINTESTINAL INFLAMMATION 4 0.0005
296 LYMPHOCYTE COUNT DECREASED 9 0.0005
297 UNDERWEIGHT 1 0.0005
298 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 3 0.0005
299 BLOOD ALBUMIN DECREASED 4 0.0005
300 DEVICE RELATED SEPSIS 1 0.0005
301 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0005
302 HYPERURICAEMIA 2 0.0005
303 NEUTROPENIC COLITIS 1 0.0005
304 OLIGURIA 3 0.0005
305 BLOOD UREA INCREASED 8 0.0005
306 ASCITES 14 0.0005
307 HALLUCINATIONS, MIXED 2 0.0005
308 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
309 NEUROGENIC BLADDER 1 0.0005
310 LIP OEDEMA 2 0.0005
311 ABNORMAL SENSATION IN EYE 2 0.0005
312 SARS-COV-2 TEST POSITIVE 6 0.0005
313 CLOSTRIDIUM TEST POSITIVE 1 0.0005
314 ACUTE RESPIRATORY DISTRESS SYNDROME 8 0.0005
315 ILEUS PARALYTIC 2 0.0004
316 METASTASES TO MENINGES 1 0.0004
317 HAEMATOCRIT INCREASED 1 0.0004
318 RESPIRATION ABNORMAL 3 0.0004
319 BREAKTHROUGH PAIN 1 0.0004
320 NEUROLOGICAL DECOMPENSATION 1 0.0004
321 METHAEMOGLOBINAEMIA 1 0.0004
322 HYPOMAGNESAEMIA 6 0.0004
323 PRURITUS GENITAL 1 0.0004
324 PLATELET COUNT DECREASED 45 0.0004
325 PULSE ABSENT 2 0.0004
326 HYPOVOLAEMIC SHOCK 2 0.0004
327 ABDOMINAL PAIN 97 0.0004
328 PULSE ABNORMAL 1 0.0004
329 BREATH SOUNDS ABNORMAL 2 0.0004
330 TACHYCARDIA 36 0.0004
331 HYPERCALCAEMIA 5 0.0004
332 TRANSAMINASES INCREASED 9 0.0004
333 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
334 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
335 PNEUMOCYSTIS JIROVECII PNEUMONIA 4 0.0004
336 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
337 ACIDOSIS 3 0.0004
338 HYPONATRAEMIA 22 0.0004
339 PERICARDIAL EFFUSION 9 0.0004
340 MYELOSUPPRESSION 14 0.0004
341 ACUTE MYELOID LEUKAEMIA 6 0.0004
342 PETECHIAE 4 0.0004
343 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
344 AREFLEXIA 1 0.0004
345 THROMBOCYTOPENIA 41 0.0004
346 METASTASES TO BONE 6 0.0004
347 RHINALGIA 1 0.0004
348 SERUM SICKNESS 1 0.0004
349 NEUTROPHIL COUNT ABNORMAL 1 0.0004
350 PERIORBITAL SWELLING 2 0.0004
351 SINUS TACHYCARDIA 5 0.0004
352 RESPIRATORY SYMPTOM 1 0.0004
353 ANAPHYLACTIC SHOCK 9 0.0003
354 SPEECH DISORDER DEVELOPMENTAL 1 0.0003
355 LIP PAIN 1 0.0003
356 RALES 2 0.0003
357 ELECTROLYTE IMBALANCE 4 0.0003
358 DEAFNESS 9 0.0003
359 SEDATION 9 0.0003
360 HYPERTRIGLYCERIDAEMIA 2 0.0003
361 WHITE BLOOD CELL COUNT INCREASED 13 0.0003
362 CREPITATIONS 1 0.0003
363 URINE ANALYSIS ABNORMAL 1 0.0003
364 ANAL INCONTINENCE 3 0.0003
365 BLOOD BILIRUBIN INCREASED 9 0.0003
366 NORMOCHROMIC NORMOCYTIC ANAEMIA 1 0.0003
367 HYPERCAPNIA 1 0.0003
368 BONE MARROW DISORDER 1 0.0003
369 CRANIOCEREBRAL INJURY 1 0.0003
370 URTICARIA 55 0.0003
371 CHEST X-RAY ABNORMAL 1 0.0003
372 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
373 ANAPHYLACTIC REACTION 18 0.0003
374 PORTAL HYPERTENSION 1 0.0003
375 CONJUNCTIVITIS 6 0.0003
376 BACTERIAL INFECTION 6 0.0003
377 NEPHROPATHY 3 0.0003
378 RESPIRATORY RATE DECREASED 1 0.0003
379 HYPOCALCAEMIA 6 0.0003
380 NON-CARDIAC CHEST PAIN 1 0.0003
381 HAEMATOTOXICITY 3 0.0003
382 PNEUMOTHORAX 5 0.0003
383 ANAEMIA 60 0.0003
384 LOSS OF THERAPEUTIC RESPONSE 1 0.0003
385 STUPOR 1 0.0003
386 VITAMIN D DEFICIENCY 3 0.0003
387 HYPOGAMMAGLOBULINAEMIA 2 0.0003
388 SHOCK 7 0.0003
389 OTITIS MEDIA 1 0.0003
390 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0003
391 RESPIRATORY FAILURE 22 0.0003
392 NEPHRITIS 1 0.0003
393 POTENTIATING DRUG INTERACTION 1 0.0003
394 BK VIRUS INFECTION 1 0.0003
395 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
396 WOUND DEHISCENCE 1 0.0003
397 NEOPLASM RECURRENCE 1 0.0003
398 SUDDEN CARDIAC DEATH 1 0.0003
399 BLOOD CREATININE INCREASED 19 0.0003
400 VENTRICULAR EXTRASYSTOLES 3 0.0003
401 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
402 FEBRILE NEUTROPENIA 19 0.0003
403 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
404 END STAGE RENAL DISEASE 5 0.0003
405 HYPERTENSION 58 0.0003
406 BLINDNESS TRANSIENT 2 0.0003
407 BLINDNESS 11 0.0003
408 CATHETER SITE INFECTION 1 0.0003
409 PNEUMONITIS 7 0.0003
410 APNOEA 2 0.0003
411 RESPIRATORY ACIDOSIS 1 0.0003
412 WHEEZING 15 0.0003
413 HAEMATOCRIT DECREASED 5 0.0003
414 PAIN 154 0.0003
415 BLEPHARITIS 1 0.0002
416 PLEURAL EFFUSION 15 0.0002
417 SECOND PRIMARY MALIGNANCY 2 0.0002
418 COAGULOPATHY 4 0.0002
419 EATING DISORDER 5 0.0002
420 RESPIRATORY DISORDER 7 0.0002
421 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
422 PSEUDOMONAS INFECTION 2 0.0002
423 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
424 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
425 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
426 DISEASE PROGRESSION 27 0.0002
427 BLOOD PRESSURE DECREASED 15 0.0002
428 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
429 BRAIN NEOPLASM 2 0.0002
430 RETINAL DETACHMENT 2 0.0002
431 ERYTHEMA MULTIFORME 2 0.0002
432 PAIN IN JAW 6 0.0002
433 PRODUCT USE IN UNAPPROVED INDICATION 52 0.0002
434 RASH VESICULAR 1 0.0002
435 HYPOKINESIA 3 0.0002
436 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
437 GASTROENTERITIS 3 0.0002
438 LIVER INJURY 5 0.0002
439 HEPATOMEGALY 2 0.0002
440 ANGIOEDEMA 9 0.0002
441 INFLAMMATORY MARKER INCREASED 1 0.0002
442 BLADDER DISORDER 2 0.0002
443 IMMUNODEFICIENCY 3 0.0002
444 PULMONARY OEDEMA 9 0.0002
445 PROTEIN URINE PRESENT 1 0.0002
446 HYPOTONIA 2 0.0002
447 CYTOKINE RELEASE SYNDROME 4 0.0002
448 FULL BLOOD COUNT DECREASED 4 0.0002
449 OSTEOPENIA 3 0.0002
450 NEUTROPHIL COUNT INCREASED 2 0.0002
451 FULL BLOOD COUNT ABNORMAL 2 0.0002
452 METABOLIC ACIDOSIS 6 0.0002
453 DECREASED ACTIVITY 2 0.0002
454 STRESS FRACTURE 1 0.0002
455 PAIN IN EXTREMITY 53 0.0002
456 HEART RATE ABNORMAL 1 0.0002
457 MALNUTRITION 2 0.0002
458 ACUTE PULMONARY OEDEMA 1 0.0002
459 THERAPY NON-RESPONDER 8 0.0002
460 STATUS EPILEPTICUS 2 0.0002
461 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
462 COUGH 49 0.0002
463 MYOCARDITIS 2 0.0002
464 ENTEROCOLITIS 1 0.0002
465 BLOOD URIC ACID INCREASED 1 0.0002
466 UNINTENTIONAL MEDICAL DEVICE REMOVAL 2 0.0002
467 VOMITING 81 0.0002
468 ORTHOSTATIC HYPOTENSION 3 0.0002
469 HYPERKALAEMIA 6 0.0002
470 HYPOVOLAEMIA 1 0.0002
471 PROTHROMBIN TIME PROLONGED 1 0.0002
472 INFUSION RELATED REACTION 11 0.0002
473 INGUINAL HERNIA 1 0.0002
474 ENCEPHALOPATHY 4 0.0002
475 INJECTION SITE EXTRAVASATION 2 0.0002
476 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
477 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
478 PNEUMONIA ASPIRATION 4 0.0002
479 OFF LABEL USE 140 0.0002
480 LIVER DISORDER 7 0.0002
481 NEUROPATHY PERIPHERAL 15 0.0002
482 CARDIAC ARREST 13 0.0002
483 HYPOTHYROIDISM 5 0.0002
484 ACUTE RESPIRATORY FAILURE 3 0.0002
485 HAEMOGLOBIN ABNORMAL 1 0.0002
486 DIPLOPIA 4 0.0002
487 CONSTIPATION 33 0.0002
488 CORONAVIRUS INFECTION 1 0.0002
489 HAEMATURIA 5 0.0001
490 ECCHYMOSIS 1 0.0001
491 HYPOGLYCAEMIA 7 0.0001
492 WEIGHT INCREASED 32 0.0001
493 RENAL IMPAIRMENT 12 0.0001
494 RIGHT VENTRICULAR FAILURE 1 0.0001
495 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
496 METASTASIS 1 0.0001
497 NEUTROPENIC SEPSIS 1 0.0001
498 LIVER FUNCTION TEST INCREASED 3 0.0001
499 HYPOACUSIS 6 0.0001
500 GRAFT VERSUS HOST DISEASE 1 0.0001
501 TONGUE DISORDER 1 0.0001
502 FLUID OVERLOAD 2 0.0001
503 RASH MACULO-PAPULAR 3 0.0001
504 RASH PAPULAR 3 0.0001
505 HALLUCINATION 10 0.0001
506 LIPASE INCREASED 1 0.0001
507 HAEMOLYSIS 1 0.0001
508 CYANOSIS 2 0.0001
509 NEUTROPENIA 17 0.0001
510 MIOSIS 1 0.0001
511 SENSORY LOSS 1 0.0001
512 RHINITIS 1 0.0001
513 VISION BLURRED 17 0.0001
514 STAPHYLOCOCCAL INFECTION 4 0.0001
515 EPISTAXIS 9 0.0001
516 LIP SWELLING 4 0.0001
517 CANDIDA INFECTION 2 0.0001
518 FACIAL PARALYSIS 1 0.0001
519 PRODUCT CONTAINER ISSUE 1 0.0001
520 ANURIA 1 0.0001
521 CARDIAC MURMUR 1 0.0001
522 COLD SWEAT 2 0.0001
523 DECREASED APPETITE 26 0.0001
524 THIRST 2 0.0001
525 HAEMOLYTIC ANAEMIA 1 0.0001
526 OROPHARYNGEAL DISCOMFORT 1 0.0001
527 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
528 TREATMENT FAILURE 9 0.0001
529 RHINORRHOEA 7 0.0001
530 PERSONALITY CHANGE 1 0.0001
531 DIARRHOEA HAEMORRHAGIC 1 0.0001
532 BLOOD SODIUM DECREASED 2 0.0001
533 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
534 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
535 DEHYDRATION 14 0.0001
536 CHOLESTASIS 2 0.0001
537 GLAUCOMA 2 0.0001
538 DYSSTASIA 3 0.0001
539 BONE PAIN 6 0.0001
540 CHILLS 12 0.0001
541 HYPERSENSITIVITY 19 0.0001
542 THERAPY CHANGE 1 0.0001
543 LEUKOPENIA 5 0.0001
544 IRRITABILITY 6 0.0001
545 BRAIN INJURY 1 0.0001
546 RASH 43 0.0001
547 FEEDING DISORDER 2 0.0001
548 EYELID PTOSIS 1 0.0001
549 EAR DISCOMFORT 1 0.0001
550 SWOLLEN TONGUE 3 0.0001
551 TRANSFUSION 1 0.0001
552 SEIZURE 11 0.0001
553 BRADYCARDIA 5 0.0001
554 BODY HEIGHT DECREASED 1 0.0001
555 SEPTIC SHOCK 4 0.0001
556 ACUTE KIDNEY INJURY 14 0.0001
557 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
558 VISUAL ACUITY REDUCED 3 0.0001
559 VIRAL INFECTION 3 0.0001
560 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
561 NECK PAIN 5 0.0001
562 CARDIAC FAILURE 7 0.0001
563 SPINAL PAIN 1 0.0001
564 MYOCLONUS 1 0.0001
565 MUSCLE RIGIDITY 1 0.0001
566 BLOOD PRESSURE FLUCTUATION 2 0.0001
567 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
568 PRESYNCOPE 2 0.0001
569 CYTOPENIA 1 0.0001
570 DYSURIA 3 0.0001
571 SMALL INTESTINAL OBSTRUCTION 1 0.0001
572 DIARRHOEA 52 0.0001
573 ILEUS 1 0.0001
574 HEPATIC FUNCTION ABNORMAL 3 0.0001
575 COVID-19 14 0.0001
576 HAEMATEMESIS 2 0.0001
577 FLUID RETENTION 4 0.0001
578 HEPATIC CYTOLYSIS 1 0.0001
579 HYPOPHAGIA 2 0.0001
580 UNRESPONSIVE TO STIMULI 2 0.0001
581 CHEST PAIN 14 0.0001
582 MALAISE 33 0.0001
583 NAUSEA 59 0.0001
584 IMPAIRED GASTRIC EMPTYING 1 0.0001
585 MOOD ALTERED 2 0.0001
586 ACUTE HEPATIC FAILURE 1 0.0001
587 PERIPHERAL COLDNESS 1 0.0001
588 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
589 VISUAL IMPAIRMENT 9 0.0001
590 RESPIRATORY ARREST 2 0.0001
591 DEVICE OCCLUSION 1 0.0001
592 BLINDNESS UNILATERAL 1 0.0001
593 LYMPHOPENIA 1 0.0001
594 HEART RATE INCREASED 7 0.0001
595 MUSCULAR WEAKNESS 8 0.0001
596 PARALYSIS 1 0.0001
597 CARDIOGENIC SHOCK 1 0.0001
598 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
599 PRODUCT USE ISSUE 13 0.0001
600 HAEMOGLOBIN DECREASED 7 0.0001
601 RENAL FAILURE 9 0.0001
602 URINARY INCONTINENCE 2 0.0001
603 STOMATITIS 4 0.0001
604 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
605 PNEUMONIA 21 0.0001
606 OROPHARYNGEAL PAIN 6 0.0001
607 ARRHYTHMIA 3 0.0001
608 DISEASE RECURRENCE 3 0.0001
609 SENSORY DISTURBANCE 1 0.0001
610 INTERSTITIAL LUNG DISEASE 3 0.0001
611 CONFUSIONAL STATE 10 0.0001
612 DYSPEPSIA 6 0.0001
613 VENTRICULAR TACHYCARDIA 1 0.0001
614 BACK PAIN 14 0.0001
615 CYTOMEGALOVIRUS INFECTION 1 0.0001
616 FUNGAL INFECTION 2 0.0001
617 AGGRESSION 3 0.0001
618 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
619 FLUSHING 6 0.0001
620 CIRCULATORY COLLAPSE 1 0.0001
621 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
622 NEUROTOXICITY 1 0.0001
623 EOSINOPHILIA 1 0.0001
624 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
625 DRUG ERUPTION 1 0.0001
626 HEADACHE 35 0.0001
627 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
628 INFECTION 8 0.0001
629 RESTLESSNESS 2 0.0001
630 SOMNOLENCE 11 0.0001
631 SEPSIS 6 0.0001
632 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
633 EYE PAIN 3 0.0001
634 INTESTINAL OBSTRUCTION 2 0.0001
635 COLITIS 2 0.0001
636 LETHARGY 3 0.0001
637 PULMONARY FIBROSIS 1 0.0001
638 DRUG PRESCRIBING ERROR 1 0.0001
639 DYSPHONIA 3 0.0001
640 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
641 ORAL HERPES 1 0.0001
642 NASAL CONGESTION 3 0.0001
643 ABNORMAL BEHAVIOUR 2 0.0001
644 TASTE DISORDER 1 0.0000
645 OEDEMA PERIPHERAL 6 0.0000
646 FEELING HOT 3 0.0000
647 ABDOMINAL DISTENSION 5 0.0000
648 CARDIO-RESPIRATORY ARREST 2 0.0000
649 HALLUCINATION, VISUAL 1 0.0000
650 HEPATOTOXICITY 1 0.0000
651 ORAL PAIN 1 0.0000
652 THROAT IRRITATION 2 0.0000
653 DRUG INTERACTION 7 0.0000
654 WEIGHT DECREASED 12 0.0000
655 ANXIETY 12 0.0000
656 PRODUCTIVE COUGH 2 0.0000
657 FATIGUE 32 0.0000
658 HYPOAESTHESIA 6 0.0000
659 SYNCOPE 4 0.0000
660 ABDOMINAL PAIN LOWER 1 0.0000
661 DRUG RESISTANCE 1 0.0000
662 DYSPNOEA 22 0.0000
663 INFLAMMATION 2 0.0000
664 RASH GENERALISED 1 0.0000
665 RESPIRATORY TRACT INFECTION 1 0.0000
666 MUSCULOSKELETAL PAIN 2 0.0000
667 GASTRITIS 1 0.0000
668 JAUNDICE 1 0.0000
669 GAIT DISTURBANCE 7 0.0000
670 TREATMENT NONCOMPLIANCE 2 0.0000
671 PRURITUS 14 0.0000
672 HAEMOPTYSIS 1 0.0000
673 WOUND 1 0.0000
674 ABDOMINAL DISCOMFORT 6 0.0000
675 RED BLOOD CELL COUNT DECREASED 1 0.0000
676 LIVER FUNCTION TEST ABNORMAL 1 0.0000
677 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
678 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
679 ABDOMINAL PAIN UPPER 7 0.0000
680 BLOOD POTASSIUM DECREASED 1 0.0000
681 CORONARY ARTERY DISEASE 1 0.0000
682 EPILEPSY 1 0.0000
683 BLOOD PRESSURE INCREASED 5 0.0000
684 INJECTION SITE RASH 1 0.0000
685 CARDIAC DISORDER 3 0.0000
686 DRUG-INDUCED LIVER INJURY 1 0.0000
687 SWELLING FACE 2 0.0000
688 CHOLELITHIASIS 1 0.0000
689 EYE DISORDER 1 0.0000
690 NEOPLASM MALIGNANT 2 0.0000
691 EYE PRURITUS 1 0.0000
692 ANGER 1 0.0000
693 ARTHRALGIA 12 0.0000
694 DELIRIUM 1 0.0000
695 HEART RATE DECREASED 1 0.0000
696 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
697 CEREBRAL HAEMORRHAGE 1 0.0000
698 MOBILITY DECREASED 2 0.0000
699 CRYING 1 0.0000
700 AGITATION 2 0.0000
701 EYE SWELLING 1 0.0000
702 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
703 PARAESTHESIA 4 0.0000
704 DISORIENTATION 1 0.0000
705 DRUG INEFFECTIVE 31 0.0000
706 URINARY TRACT INFECTION 4 0.0000
707 DRY SKIN 3 0.0000
708 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
709 RENAL DISORDER 1 0.0000
710 COGNITIVE DISORDER 1 0.0000
711 MIGRAINE 2 0.0000
712 RASH ERYTHEMATOUS 1 0.0000
713 LUNG DISORDER 1 0.0000
714 THERAPY CESSATION 1 0.0000
715 PERIPHERAL SWELLING 3 0.0000
716 ILLNESS 2 0.0000
717 ECZEMA 1 0.0000
718 SPEECH DISORDER 1 0.0000
719 PANCREATITIS 1 0.0000
720 DEPRESSED MOOD 1 0.0000
721 ASTHENIA 7 0.0000
722 RASH PRURITIC 1 0.0000
723 HAEMATOCHEZIA 1 0.0000
724 INFLUENZA 2 0.0000
725 TOXICITY TO VARIOUS AGENTS 3 0.0000
726 ASTHMA 2 0.0000
727 THERAPEUTIC RESPONSE DECREASED 1 0.0000
728 DEEP VEIN THROMBOSIS 1 0.0000
729 PRODUCT DOSE OMISSION 1 0.0000
730 DEATH 13 0.0000
731 HEPATIC ENZYME INCREASED 1 0.0000
732 BURNING SENSATION 1 0.0000
733 SLEEP DISORDER 1 0.0000
734 SKIN BURNING SENSATION 1 0.0000
735 DYSGEUSIA 1 0.0000
736 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
737 TREMOR 2 0.0000
738 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
739 MYALGIA 2 0.0000
740 MYOCARDIAL INFARCTION 2 0.0000
741 GASTROINTESTINAL DISORDER 1 0.0000
742 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
743 SWELLING 1 0.0000
744 BLOOD GLUCOSE INCREASED 2 0.0000
745 DYSPHAGIA 1 0.0000
746 DRUG INTOLERANCE 1 0.0000
747 ATRIAL FIBRILLATION 1 0.0000
748 CHEST DISCOMFORT 1 0.0000
749 SINUSITIS 1 0.0000
750 ERYTHEMA 2 0.0000
751 HAEMORRHAGE 1 0.0000
752 FEELING ABNORMAL 2 0.0000
753 JOINT SWELLING 1 0.0000
754 HYPERHIDROSIS 1 0.0000
755 INSOMNIA 2 0.0000
756 CONDITION AGGRAVATED 2 0.0000
757 DIZZINESS 3 0.0000
758 FALL 2 0.0000
759 CEREBROVASCULAR ACCIDENT 1 0.0000
760 NO ADVERSE EVENT 1 0.0000
761 MUSCLE SPASMS 1 0.0000
762 NASOPHARYNGITIS 1 0.0000
763 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
764 OVERDOSE 1 0.0000
765 PRODUCT DOSE OMISSION ISSUE 1 0.0000